Trial Profile
Effects of intravitreal 0.7 mg dexamethasone implants (Ozurdex) on arterial and venous oxygen saturation, retinal vessel diameter, and retrobulbar blood flow velocity in patients with macular edema due to retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2017
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 28 Oct 2017 New trial record
- 01 Oct 2017 Results published in the Investigative Ophthalmology and Visual Science